OCULAR THERAPEUTIX, INC business relationships
Companies named in OCULAR THERAPEUTIX, INC’s 10-K filed 2026-02-05, and public companies whose annual reports name OCULAR THERAPEUTIX, INC. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 5.0 / 10
- AI naming
- 27 / 100 Top 1% in its category
- Agent readiness
- 30 / 100
- AI adoption
- 0 / 100
Named in OCULAR THERAPEUTIX, INC’s annual report 2
“For example, our former collaborator Regeneron terminated our collaboration in August 2021.” SEC filing
“For example, three of our licensed patents related to ReSure Sealant were invalidated and rendered unenforceable following their assertion by Integra LifeSciences Holdings Corporation, another licensee of Incept.” SEC filing
Links are read automatically from public company filings, so every link carries the sentence it came from.
Not investment advice. Scores, rankings and connections are automated estimates from public sources, provided as is. Connections are read automatically from public company filings and may be incomplete or wrong. To correct or remove a company page or a connection, email [email protected]. Company names and logos belong to their owners. Showing them does not mean the company endorses Engagemii or that Engagemii endorses it. Terms